Pulmonary Immune Disorders

Pulmonary immune disorders encompass a diverse spectrum of conditions in which the body’s immune system contributes to inflammation, injury, or dysfunction within the lungs. These disorders may arise from autoimmune processes, hypersensitivity reactions, or immune deficiencies that increase susceptibility to infections. Common examples include sarcoidosis, hypersensitivity pneumonitis, autoimmune-related interstitial lung diseases, and pulmonary manifestations of systemic disorders such as rheumatoid arthritis or systemic lupus erythematosus. Pulmonary immune disorders can manifest with persistent cough, breathlessness, chest pain, or recurrent infections, and diagnosis often requires a combination of imaging, lung biopsies, bronchoalveolar lavage, and immunologic testing to establish underlying mechanisms. Management strategies vary according to the condition but frequently involve immunosuppressive therapies, including corticosteroids, biologics, or other disease-modifying agents to control inflammation and prevent progressive lung damage. Supportive measures such as pulmonary rehabilitation, infection prevention, and monitoring for drug-related toxicity also play a crucial role in patient care. Multidisciplinary collaboration among pulmonologists, immunologists, and rheumatologists ensures comprehensive evaluation and tailored treatment planning. Research in pulmonary immune disorders is advancing rapidly, with novel biomarkers, targeted biologics, and personalized immunomodulatory approaches showing promise in improving outcomes. By combining accurate diagnosis, effective immunotherapy, and long-term monitoring, the management of pulmonary immune disorders seeks to preserve lung function, minimize exacerbations, and enhance quality of life, highlighting the importance of immune regulation in maintaining respiratory health.